2015-2016 Influenza Vaccination Guidelines

Updated recommendations on influenza vaccination for the 2015-16 season have been issued by the CDC's Advisory Committee on Immunization Practices. As reported in MMWR, changes from the 2014-2015 season include the following:

• Trivalent vaccines will include A/California/7/2009 (H1N1)-like virus, an A/Switzerland/9715293/2013 (H3N2)-like virus, and a B/Phuket/3073/2013-like (Yamagata lineage) virus. These A (H3N2) and B viruses are different from the previous season.
• The Fluzone Intradermal Quadrivalent vaccine is expected to replace the trivalent Fluzone Intradermal vaccine for adults aged 18 to 64.
• Children aged 6 months to 8 years who are receiving their first influenza vaccine still need two doses at least 4 weeks apart, but special consideration of influenza A(H1N1)pdm09 vaccination is no longer needed, since current vaccines incorporate that viral antigen.
• Live-attenuated vaccine (previously preferred for children aged 2–8 years) is no longer recommended over inactivated vaccine, because observational studies failed to support the superiority of live-attenuated vaccine seen in randomized trials.

Free links:

1. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6430a3.htm 
2. http://www.jwatch.org/na38646/2015/07/29/high-dose-influenza-vaccine-no-more-effective-standard
   

CHEST 2015 Annual Meeting in Montreal Canada

We are happy to invite you to Chest 2015 meeting!

Join CHEST 2015 Annual Meeting in Montreal Canada, your connection to learning opportunities that will help optimize the clinical decisions you make. We’ve packed as many education deliverables as we can into 4 days to make the BIGGEST impact on your professional development and patient care. We’ll offer a full schedule of sessions that address topics from an interdisciplinary and interprofessional perspective to ensure a comprehensive (and BIG) understanding of chest medicine. And, our international faculty and attendees will give you a worldwide viewpoint on clinical issues. It doesn’t get much BIGGER than that!

Don’t miss:

• Interdisciplinary programs
• Simulation programs
• Postgraduate courses
• More than 300 general sessions
• Expanded MOC opportunities
• Original investigation presentations
• New diagnostic and treatment solutions in the exhibit hall

more info:
http://chestmeeting.chestnet.org/

Occupational Asthma

Today we are presenting new review on Occupational Asthma from NEJM!

Asthma is common in the general population, including those in the workforce.Work exposures can cause or exacerbate asthma and can also be associated with asthma variants as well as symptoms that mimic asthma (e.g., the irritable larynx syndrome). In addition, even non–work-related asthma can affect the ability to work. This review focuses on current data about occupational asthma, defined as asthma due to conditions attributable to work exposures and not to causes outside the workplace.

Occupational AsthmaSusan M. Tarlo, M.B., B.S., and Catherine Lemiere, M.D.N Engl J Med 2014; 370:640-649 February 13, 2014 DOI: 10.1056/NEJMra1301758

LUNGUAGE and ReSpublic: new Respiratory resources

Dear Respiratory friends, we are happy to launch LUNGUAGE and ReSpublic: two new Respiratory Resources. Here we will share all new information about all respiratory!

We are encouraging everybody to share with us all relevant respiratory resources, because LUNGUAGE and ReSpublic will be the First Free open sources of Respiratory information for Health care professionals, patients and all public interested in lung health! 


Our LUNGUAGE is Respiratory!